We revealed that C60 enhanced major histocompatibility complex (MHC) class I-dependent antigen presentation machinery by activating 20S immunoproteasome, which consequently increased the differentiation of tumor antigen-specific CD8+ T cells as major players in tumor killing. Here, CD8A is linked to neoplasm.